Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statistical validation of intermediate endpoints for chronic diseases.

L S Freedman1, B I Graubard, A Schatzkin

  • 1Biometry Branch, National Cancer Institute, Bethesda, MD 20892.

Statistics in Medicine
|January 30, 1992
PubMed
Summary

This study explores Prentice

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A historical cohort study on glycemic-control and cancer-risk among patients with diabetes.

Cancer epidemiology·2018
Same author

Associations between circulating sex steroid hormones and leukocyte telomere length in men in the National Health and Nutrition Examination Survey.

Andrology·2018
Same author

Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey.

Blood cancer journal·2017
Same author

Marijuana use and serum testosterone concentrations among U.S. males.

Andrology·2017
Same author

A prospective study of coffee intake and pancreatic cancer: results from the NIH-AARP Diet and Health Study.

British journal of cancer·2015
Same author

Reproductive factors, exogenous hormone use and risk of hepatocellular carcinoma among US women: results from the Liver Cancer Pooling Project.

British journal of cancer·2015

Area of Science:

  • Epidemiology
  • Biostatistics
  • Chronic Disease Research

Background:

  • Intermediate endpoints are crucial for evaluating chronic disease interventions.
  • Statistical validation of these endpoints ensures reliable study outcomes.
  • Prentice's criterion offers a method for assessing intermediate endpoint validity.

Purpose of the Study:

  • To discuss the implementation of Prentice's criterion for statistically validating intermediate endpoints in chronic disease studies.
  • To evaluate the strength of validation based on the magnitude of the unadjusted exposure effect.

Main Methods:

  • Utilizing cohort or intervention studies to assess exposure/intervention effects.
  • Adjusting for the intermediate endpoint to observe the reduction in the primary effect.
  • Employing model selection techniques as required by the criterion.

Main Results:

  • Validation typically necessitates model selection.
  • Weak validation is indicated when the unadjusted effect is less than four times its standard error.
  • Stronger validation statements (e.g., explaining 50-75% of the effect) are possible with significant unadjusted effects.

Conclusions:

  • Prentice's criterion provides a framework for validating intermediate endpoints.
  • The strength of statistical validation is directly related to the unadjusted exposure effect's significance.
  • Careful analysis and model selection are key to robust intermediate endpoint validation.

Related Experiment Videos